Browse > Article
http://dx.doi.org/10.4110/in.2010.10.5.173

Cell to Cell Interaction Can Activate Membrane-bound APRIL Which Are Expressed on Inflammatory Macrophages  

Lee, Sang-Min (From School of Life Sciences and Biotechnology, Kyungpook National University)
Kim, Won-Jung (From School of Life Sciences and Biotechnology, Kyungpook National University)
Suk, Kyoung-Ho (Department of Pharmacology, Brain Science and Engineering Institute, College of Medicine, Kyungpook National University)
Lee, Won-Ha (From School of Life Sciences and Biotechnology, Kyungpook National University)
Publication Information
IMMUNE NETWORK / v.10, no.5, 2010 , pp. 173-180 More about this Journal
Abstract
Background: APRIL, originally known as a cytokine involved in B cell survival, is now known to regulate the inflammatory activation of macrophages. Although the signal initiated from APRIL has been demonstrated, its role in cellular activation is still not clear due to the presence of BAFF, a closely related member of TNF superfamily, which share same receptors (TACI and BCMA) with APRIL. Methods: Through transfection of siRNA, BAFF-deficient THP-1 cells (human macrophage-like cells) were generated and APRIL-mediated inflammatory activities were tested. The expression patterns of APRIL were also tested in vivo. Results: BAFF-deficient THP-1 cells responded to APRIL-stimulating agents such as monoclonal antibody against APRIL and soluble form of TACI or BCMA. Furthermore, co-incubation of the siBAFF-deficient THP-1 cells with a human B cell line (Ramos) resulted in an activation of THP-1 cells which was dependent on interactions between APRIL and TACI/BCMA. Immunohistochemical analysis of human pathologic samples detected the expression of both APRIL and TACI in macrophage-rich areas. Additionally, human macrophage primary culture expressed APRIL on the cell surface. Conclusion: These observations indicate that APRIL, which is expressed on macrophages in pathologic tissues with chronic inflammation, may mediate activation signals through its interaction with its counterparts via cell-to-cell interaction.
Keywords
Macrophage; APRIL; TNFSF; Inflammation; Signaling transduction;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ross R: Atherosclerosis--an inflammatory disease. N Engl J Med 340;115-126, 1999   DOI   ScienceOn
2 Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81;1607-1613, 1993
3 Bresnihan B: Pathogenesis of joint damage in rheumatoid arthritis. J Rheumatol 26;717-719, 1999
4 Yanni G, Whelan A, Feighery C, Bresnihan B: Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 53;39-44, 1994   DOI   ScienceOn
5 Tamada K, Shimozaki K, Chapoval AI, Zhai Y, Su J, Chen SF, Hsieh SL, Nagata S, Ni J, Chen L: LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164;4105-4110, 2000   DOI
6 van Lent PL, Holthuysen AE, van den Bersselaar LA, van Rooijen N, Joosten LA, van de Loo FA, van de Putte LB,van den Berg WB: Phagocytic lining cells determine local expression of inflammation in type II collagen-induced arthritis. Arthritis Rheum 39;1545-1555, 1996   DOI   ScienceOn
7 Kolfschoten GM, Pradet-Balade B, Hahne M, Medema JP: TWE-PRIL; a fusion protein of TWEAK and APRIL. Biochem Pharmacol 66;1427-1432, 2003   DOI   ScienceOn
8 Kelly K, Manos E, Jensen G, Nadauld L, Jones DA: APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res 60;1021-1027, 2000
9 Shu HB, Hu WH, Johnson H: TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J Leukoc Biol 65;680-683, 1999   DOI
10 Mackay F, Schneider P, Rennert P, Browning J: BAFF AND APRIL: a tutorial on B cell survival. Annu Rev Immunol 21;231-264, 2003   DOI   ScienceOn
11 Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML: Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 198;937-945, 2003   DOI   ScienceOn
12 Ng LG, Mackay CR, Mackay F: The BAFF/APRIL system: life beyond B lymphocytes. Mol Immunol 42;763-772, 2005   DOI   ScienceOn
13 Schneider P: The role of APRIL and BAFF in lymphocyte activation. Curr Opin Immunol 17;282-289, 2005   DOI   ScienceOn
14 Jeon ST, Kim WJ, Lee SM, Lee MY, Park SB, Lee SH, Kim IS, Suk K, Choi BK, Choi EM, Kwon BS, Lee WH: Reverse signaling through BAFF differentially regulates the expression of inflammatory mediators and cytoskeletal movements in THP-1 cells. Immunol Cell Biol 88;148-156, 2010   DOI   ScienceOn
15 Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE: Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21;2004-2010, 2001   DOI   ScienceOn
16 Kim WJ, Lee WH: LIGHT is expressed in foam cells and involved in destabilization of atherosclerotic plaques through induction of matrix metalloproteinase-9 and IL-8. Immune Netw 4;116-122, 2004   DOI
17 Colli S, Eligini S, Lalli M, Camera M, Paoletti R, Tremoli E: Vastatins inhibit tissue factor in cultured human macrophages. A novel mechanism of protection against atherothrombosis. Arterioscler Thromb Vasc Biol 17;265- 272, 1997   DOI   ScienceOn
18 Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE,Sordat B, Rimoldi D, Tschopp J: APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 188;1185-1190, 1998   DOI   ScienceOn
19 Lesnik P, Rouis M, Skarlatos S, Kruth HS, Chapman MJ: Uptake of exogenous free cholesterol induces upregulation of tissue factor expression in human monocyte-derived macrophages. Proc Natl Acad Sci U S A 89;10370-10374, 1992   DOI   ScienceOn
20 Pradet-Balade B, Medema JP, Lopez-Fraga M, Lozano JC, Kolfschoten GM, Picard A, Martínez-A C, Garcia-Sanz JA, Hahne M: An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein. EMBO J 21;5711-5720, 2002   DOI   ScienceOn
21 Libby P: Inflammation in atherosclerosis. Nature 420;868- 874, 2002   DOI   ScienceOn
22 Libby P, Geng YJ, Aikawa M, Schoenbeck U, Mach F, Clinton SK, Sukhova GK, Lee RT: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 7;330-335, 1996   DOI   ScienceOn
23 Lee SM, Jeon ST, Kim WJ, Suk KH, Lee WH: Macrophages express membrane bound form of APRIL that can generate immunomodulatory signals. Immunology 131;350-356, 2010   DOI   ScienceOn
24 Mulherin D, Fitzgerald O, Bresnihan B: Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39;115-124, 1996   DOI   ScienceOn
25 Van Lent PL, Holthuysen AE, Van Rooijen N, Van De Putte LB, Van Den Berg WB: Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis. Ann Rheum Dis 57;408-413, 1998   DOI   ScienceOn
26 Dillon SR, Gross JA, Ansell SM, Novak AJ: An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 5;235-246, 2006   DOI   ScienceOn